24 results
8-K
EDIT
Editas Medicine, Inc.
13 Apr 23
Departure of Directors or Certain Officers
5:09pm
consortium whose objective is to accelerate the development of small molecule therapeutics for potential viral pandemic agents. Dr. Levy received his B.A
DEFA14A
h5ed56zo
21 May 21
Additional proxy soliciting materials
6:03am
424B5
m5r q4x4p
21 Jan 21
Prospectus supplement for primary offering
4:42pm
424B5
vp3fe
19 Jan 21
Prospectus supplement for primary offering
4:33pm
8-K
EX-99.1
lxo2 q2nze
5 Nov 20
Editas Medicine Announces Third Quarter 2020 Results and Update
4:17pm